| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKTIP
|
AKT interacting protein
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH2
|
alkB, alkylation repair homolog 2 (E. coli)
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
|
|
ARRB2
|
arrestin, beta 2
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCR
|
breakpoint cluster region
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNY
|
cyclin Y
|
|
CD69
|
CD69 molecule
|
|
CDC73
|
cell division cycle 73
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CROCC
|
ciliary rootlet coiled-coil, rootletin
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CUL2
|
cullin 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DAXX
|
death-domain associated protein
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEK
|
DEK proto-oncogene
|
|
E2F1
|
E2F transcription factor 1
|
|
EBNA1BP2
|
EBNA1 binding protein 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FEM1B
|
fem-1 homolog b (C. elegans)
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FUS
|
FUS RNA binding protein
|
|
GATA2
|
GATA binding protein 2
|
|
GLI1
|
GLI family zinc finger 1
|
|
GOLPH3
|
golgi phosphoprotein 3 (coat-protein)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL13
|
interleukin 13
|
|
IL18BP
|
interleukin 18 binding protein
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KIAA1524
|
KIAA1524
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF10
|
Kruppel-like factor 10
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KSR1
|
kinase suppressor of ras 1
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCN2
|
lipocalin 2
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMO4
|
LIM domain only 4
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR146A
|
microRNA 146a
|
|
MIR30D
|
microRNA 30d
|
|
MIR520B
|
microRNA 520b
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
PARK7
|
parkinson protein 7
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PGR
|
progesterone receptor
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAGL2
|
pleiomorphic adenoma gene-like 2
|
|
PML
|
promyelocytic leukemia
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTMA
|
prothymosin, alpha
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RET
|
ret proto-oncogene
|
|
RNF4
|
ring finger protein 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SET
|
SET nuclear proto-oncogene
|
|
SKI
|
SKI proto-oncogene
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD7
|
SMAD family member 7
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG9
|
sperm associated antigen 9
|
|
SQSTM1
|
sequestosome 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
STMN1
|
stathmin 1
|
|
TADA3
|
transcriptional adaptor 3
|
|
TBP
|
TATA box binding protein
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TNPO1
|
transportin 1
|
|
TP53
|
tumor protein p53
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBR4
|
ubiquitin protein ligase E3 component n-recognin 4
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
YAP1
|
Yes-associated protein 1
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF268
|
zinc finger protein 268
|
